Insights into the Worldwide Hemoglobin Testing Market to 2024 – A $2.8 Billion Opportunity, Driven by Favourable Reimbursement Under Various Health Insurance Policies – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global hemoglobin testing market was worth US$ 1.7 Billion in 2018. Looking forward, the market is forecast to reach a value of US$ 2.8 Billion by 2024, registering a CAGR of 8.5% during 2019-2024.

An increasing prevalence of chronic disorders such as anemia and diabetes represent a key factor driving the global hemoglobulin testing market. In 2018, an estimated 490 Million people around the world suffered from diabetes. The prevalence of diabetes is currently being catalysed by an increasing ageing population, poor dietary habits, sedentary lifestyles and rising levels of obesity. Patients suffering from diabetes need to undergo tests to measure blood glucose and HbA1c levels regularly, driving the demand for such tests.

Moreover, factors such as favourable reimbursement of hemoglobin testing under various health insurance policies is also catalyzing the growth of the market. However, in many countries, medical insurance doesn't fully reimburse the cost of hemoglobin testing, but with partial payment and other coverages, consumers are increasingly adopting regular and periodic tests in order to check and maintain their overall health.

Furthermore, factors such as improving health infrastructure, increasing per capita expenditure on health care, rising awareness for blood-related ailments, ageing population, technological advancements, etc. are also projected to drive the global hemoglobin testing market in the coming years.

Key Questions Answered

• How has the global hemoglobin testing market performed so far and how will it perform in the coming years?
• What are the key regional markets in the global hemoglobin testing industry?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the global hemoglobin testing industry?
• What are the key driving factors and challenges in the global hemoglobin testing industry?
• What is the structure of the global hemoglobin testing industry and who are the key players?
• What is the degree of competition in the global hemoglobin testing industry?
• What are the profit margins in the global hemoglobin testing industry?

Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Hemoglobin Testing Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Product

5.4 Market Breakup by Technology

5.5 Market Breakup by End-User

5.6 Market Breakup by Region

5.7 Market Forecast

6 Market Breakup by Product

6.1 Reagents and Consumables

6.2 Equipment

7 Market Breakup by Technology

7.1 Chromatograph

7.2 Immunoassay

7.3 Other

8 Market Breakup by End-User

8.1 Laboratories

8.2 Hospitals

8.3 Research centers

9 Market Breakup by Region

9.1 Europe

9.2 North America

9.3 Asia Pacific

9.4 Middle East and Africa

9.5 Latin America

10 SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

14.3.1 Abbott

14.3.2 Bio-Rad Laboratories

14.3.3 Danaher

14.3.4 EKF Diagnostics

14.3.5 F. Hoffmann-La Roche

14.3.6 Siemens Healthineers

14.3.7 Thermo Fisher Scientific

14.3.8 Alere

14.3.9 ACON Laboratories

14.3.10 ARKRAY

14.3.11 Bayer Medical Care

14.3.12 Daiichi Biotech

14.3.13 DiaSys Diagnostic Systems

14.3.14 Epinex Diagnostics

14.3.15 Erba Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/8cbi7o

View source version on businesswire.com: https://www.businesswire.com/news/home/20190412005406/en/

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Coagulation and Hemostasis Testing

Source: Research and Markets